698 filings
Page 6 of 35
4
3mqjkq
13 Mar 23
ZEVRA THERAPEUTICS / David S Tierney ownership change
7:54am
4
5l7r 2fbgmc2cj
13 Mar 23
ZEVRA THERAPEUTICS / Richard W Pascoe ownership change
7:53am
8-K
n5kdz2ar
13 Mar 23
Regulation FD Disclosure
6:25am
UPLOAD
gpoxm5uzeauqczkj
10 Mar 23
Letter from SEC
12:00am
S-8
7hvxs6
7 Mar 23
Registration of securities for employees
5:29pm
S-8
5m0jf1fv ch22
7 Mar 23
Registration of securities for employees
5:28pm
DEFA14A
en7hj2ico00s85jqrco
7 Mar 23
Additional proxy soliciting materials
4:42pm
8-K
m8k9h3q4
7 Mar 23
Zevra Therapeutics Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Corporate Updates
8:20am
PRER14A
k5ewwnnbemeitv6
6 Mar 23
Preliminary revised proxy
4:39pm
CORRESP
641tx v116
6 Mar 23
Correspondence with SEC
12:00am
DFAN14A
vkucp9m3v8jv81he2 ov
3 Mar 23
Additional proxy materials by non-management
5:11pm
PREN14A
qrxac6cct9hkbnev ez
3 Mar 23
Preliminary proxy statement filed by non-management
3:11pm
UPLOAD
n1r75twyu7krb
3 Mar 23
Letter from SEC
12:00am
DEFA14A
qugix35wk
27 Feb 23
Additional proxy soliciting materials
4:53pm
8-K
nk1s6c
27 Feb 23
Regulation FD Disclosure
4:47pm
PREC14A
2567zrsvzcin04vz
27 Feb 23
Preliminary proxy with contested solicitation
4:10pm
8-K
yvws8kl prp
23 Feb 23
Amendments to Articles of Incorporation or Bylaws
9:29pm
8-K
gwx g7wsb18jsbu3v2
24 Jan 23
KemPharm Issues Letter to Shareholders
8:24pm
8-K
sul80zqw4ulzmc3dce
20 Jan 23
Other Events
5:05pm